National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Statutory Rules

1978 No. 47

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953*

WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953 that a drug or medicinal preparation that was not a pharmaceutical benefit under that Act immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953, namely the drugs and medicinal preparations specified in Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.

Dated this twenty-second day of March 1978.

ZELMAN COWEN

Governor-General

By His Excellency’s Command,

(SGD) RALPH J. HUNT

Minister of State for Health

_______

_________________________________________________________________________________

* Notified in the Commonwealth of Australia Gazette on 1978.

11131/78 Cat. No. —Recommended retail price 15c 12/14.3.1978

AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS*

Commencement

1.These Regulations shall come into operation on 1 April 1978.

Schedule 1

2.Schedule 1 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out on Schedule 1.

Schedule 2

3.Schedule 2 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2.

Schedule 3

4.Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3.

Schedule 5

5.Schedule 5 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4.

__________

SCHEDULE 1 Regulation 2

AMENDMENTS OF SCHEDULE 1 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. Omit item 35.

2. Omit item 450.

3. Omit item 517.

4. After item 579 insert the following item:

“ 579a Stanolone Tablets ”.

5. After item 613 insert the following item:

“ 613a Thiambutosine Tablets ”.

6. Omit item 634.

___________

SCHEDULE 2 Regulation 3

AMENDMENTS OF SCHEDULE 2TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. Omit item 15, substitute the following items:
“ 15 ‘ AMINOGRAN FOOD SUPPLEMENT ’	—
“ 15a  ‘ AMINOGRAN MINERAL MIXTURE ’	— ”.
2. After item 30 insert the following item:	— ”.
“ 30a  Betamethasone Dipropionate	— ”.
3. After item 61 insert the following item:
“ 61a  Desmopressin	— ”.

____________

SCHEDULE 3 Regulation 4

AMENDMENTS OF SCHEDULE 3 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. Omit item 26, substitute the following items:

“ 26  ‘ AMINOGRAN FOOD SUPPLEMENT ’

“ 26a  ‘ AMINOGRAN MINERAL MIXTURE ’ ”.

2. After item 44 insert the following item:

“ 44a  Betamethasone Dipropionate ”.

3. After item 100 insert the following item:

“ 100a  Desmopressin ”.

_________________________________________________________________________________

* Statutory Rules 1960, No. 17 as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114: 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; 1971, Nos. 44, 101, 136 and 154; 1972, Nos. 32, 121 and 205; 1973, Nos. 15, 57, 139 and 229; 1974, Nos. 37, 126 and 222; 1975, Nos. 50, 148 and 209; 1976, Nos. 84, 150, 195 and 255; and 1977, Nos. 39, 125 and 221.

SCHEDULE 3—continued

4. After item 175 insert the following item:

“ 175a Intraperitoneal Dialysis Solutions, Concentrated ”.

5. Omit item 227.

6. After item 301 insert the following item:

“ 301a Sodium Valproate ”.

____________

SCHEDULE 4 Regulation 5

AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. Omit item 9, substitute the following items:
“ 9  ‘ AMINOGRAN FOOD SUPPLEMENT ’	Phenylketonuria
“ 9a  ‘ AMINOGRAN MINERAL MIXTURE ’	Phenylketonuria ”.
2. Omit item 111a, substitute the following item:
“ 111a Metoprolol Tartrate	Frequent disabling angina without evidence of cardiac failure
Hypertension ”.
3. Omit item 119, substitute the following item:
“ 119 (1) Nitrofurantoin, B.P.	Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to nitrofurantoin, or where the patient is sensitive to sulphonamides ”.
(2) Nitrofurantoin Tablets, B.P.
4. After item 130 insert the following item:
“ 130a Pentazocine Lactate Injection, B.P.	Disabling pain associated with malignant neoplasia or self-limiting disorders of short duration which fail to respond to non-narcotic analgesics ”.
5. After item 146 insert the following item:
“ 146a Propantheline Tablets, B.P.	With the written authority of the Director-General, chronic neurogenic incontinence of urine ”.
6. After item 153 insert the following item:
“ 153a Sodium Cromoglycate, B.P.	With the written authority of the Director-General, allergic rhinitis not responding to other treatment ”.
7. After item 155 insert the following item:
“ 155a  Sodium Valproate	Epilepsy ”.
8. Omit item 158.

               

Printed by Authority by the Commonwealth Government Printer